Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CEO Margaret Tooth sold 8,884 shares of the company’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $43.73, for a total value of $388,497.32. Following the completion of the sale, the chief executive officer owned 141,345 shares of the company’s stock, valued at $6,181,016.85. This represents a 5.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Margaret Tooth also recently made the following trade(s):
- On Thursday, September 25th, Margaret Tooth sold 8,961 shares of Trupanion stock. The stock was sold at an average price of $41.88, for a total value of $375,286.68.
Trupanion Stock Performance
Shares of TRUP stock opened at $40.48 on Friday. The firm has a market cap of $1.74 billion, a price-to-earnings ratio of 155.70 and a beta of 1.83. The company’s 50 day moving average is $43.74 and its 200 day moving average is $46.11. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.32. Trupanion, Inc. has a 52-week low of $31.00 and a 52-week high of $57.90.
Institutional Investors Weigh In On Trupanion
Several institutional investors have recently bought and sold shares of the company. Jump Financial LLC lifted its stake in shares of Trupanion by 27.5% during the first quarter. Jump Financial LLC now owns 87,673 shares of the financial services provider’s stock worth $3,268,000 after buying an additional 18,919 shares during the period. Palisade Capital Management LP lifted its stake in shares of Trupanion by 36.7% during the first quarter. Palisade Capital Management LP now owns 244,354 shares of the financial services provider’s stock worth $9,107,000 after buying an additional 65,653 shares during the period. Russell Investments Group Ltd. lifted its stake in shares of Trupanion by 277.7% during the first quarter. Russell Investments Group Ltd. now owns 34,643 shares of the financial services provider’s stock worth $1,291,000 after buying an additional 25,471 shares during the period. Banque Pictet & Cie SA acquired a new stake in shares of Trupanion during the first quarter worth $439,000. Finally, Landscape Capital Management L.L.C. acquired a new stake in shares of Trupanion during the first quarter worth $5,695,000.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on TRUP shares. Stifel Nicolaus lifted their price objective on shares of Trupanion from $41.00 to $45.00 and gave the company a “hold” rating in a report on Friday, August 8th. Weiss Ratings reissued a “hold (c-)” rating on shares of Trupanion in a report on Wednesday, October 8th. Cantor Fitzgerald raised shares of Trupanion to a “hold” rating in a report on Wednesday, August 13th. Finally, Piper Sandler raised their target price on shares of Trupanion from $62.00 to $67.00 and gave the company an “overweight” rating in a research note on Friday, August 8th. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $54.75.
View Our Latest Stock Report on Trupanion
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- How to Start Investing in Real Estate
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- How to Capture the Benefits of Dividend Increases
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- 3 Tickers Leading a Meme Stock Revival
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
